Midlife Plasma Aβ and Late-Life Risk of Cognitive Impairment: The Atherosclerosis Risk in Communities Study

Plasma-based biomarkers of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease, show promise in predicting cognitive impairment and mapping onto cerebral amyloidosis, but little is known about how midlife plasma Aβ associates with late-life cognitive outcomes. Midlife plasma varia...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Innov Aging
Asıl Yazarlar: Sullivan, Kevin, Blackshear, Chad, Sharrett, A Richey, Gottesman, Rebecca, Knopman, David, Windham, B Gwen, Griswold, Michael, Mosley, Thomas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7740202/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igaa057.810
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller